China Faces Scrutiny Over Gene Therapy Deaths and Regulatory Loopholes
By Theresa Gaffney · STAT News · 2026-08-19

STAT News reports that three fatalities in Chinese cell and gene therapy trials have triggered global concern regarding investigator-initiated clinical pathways. These specific regulatory frameworks allow domestic physicians to test experimental treatments without formal authoriz
STAT News reports that three fatalities in Chinese cell and gene therapy trials have triggered global concern regarding investigator-initiated clinical pathways. These specific regulatory frameworks allow domestic physicians to test experimental treatments without formal authoriz